This is a routine CFO employment agreement with no unexpected departure or material change in compensation structure. Monitor for any future equity award grants tied to this agreement, but the filing itself does not warrant a trading response.
Price Chart
Executive Summary
Candel Therapeutics entered into a new employment agreement with CFO Charles Schoch on June 12, 2026, formalizing his at-will employment with an annual base salary of $468,600 and a target bonus of 40% of base salary. The agreement is a routine compensation arrangement with standard severance provisions including nine months of base salary plus target bonus upon qualifying termination, and includes single-trigger accelerated vesting of time-based equity awards upon a change in control followed by termination. No departures, financial results, or material business developments were disclosed.
Key Facts
- CFO Charles Schoch entered into a new employment agreement effective June 12, 2026
- Annual base salary of $468,600 with target bonus of 40% of base salary
- Severance upon termination without cause or for good reason: 9 months base salary plus target bonus, payable over 9 months
- Time-based equity awards accelerate fully if termination occurs within 1 month before or 12 months after a change in control
- Standard confidentiality, non-competition, and non-solicitation covenants apply
Financial Impact
No material financial impact disclosed. Maximum severance obligation is $468,600 x 0.75 (9 months) + $187,440 (target bonus) = approximately $538,890 plus COBRA contributions, contingent on termination. No new equity grant amounts disclosed.
Risk Factors
- No risks identified from this routine compensation filing
- Standard change-in-control acceleration provision but no imminent transaction referenced
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001841387-26-000007 |
| Document: cadl-20260612.htm | 0001841387-26-000007 |
| Document: 0001841387-26-000007-index-headers.html | 0001841387-26-000007 |
| Document: 0001841387-26-000007-index.html | 0001841387-26-000007 |
| Document: 0001841387-26-000007.txt | 0001841387-26-000007 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 25d ago | Press Release | $10.16 | awaiting T+60 | — | $7.79 (−23.33%) |
Sep 30, 2026 26d ago | Press Release | $10.44 | awaiting T+60 | — | $7.79 (−25.38%) |
Sep 10, 2026 6w ago | 8-K | $11.33 | awaiting T+60 | — | $7.79 (−31.24%) |
Sep 9, 2026 6w ago | 8-K | $11.33 | awaiting T+60 | — | $7.79 (−31.24%) |
Aug 15, 2026 10w ago | Institutional Cluster | $12.16 | awaiting T+60 | — | $7.79 (−35.94%) |
Aug 13, 2026 10w ago | 8-K | $11.80 | awaiting T+60 | — | $7.79 (−33.98%) |
Aug 13, 2026 10w ago | Press Release | $11.80 | awaiting T+60 | — | $7.79 (−33.98%) |
Aug 3, 2026 12w ago | Press Release | $10.07 | awaiting T+60 | — | $7.79 (−22.64%) |
Jul 1, 2026 16w ago | Insider Cluster | $9.83 $11.19 | ▲ +13.84% | ▲ +11.04% | $7.79 (−20.75%) |
Jul 1, 2026 16w ago | Insider Cluster | $9.83 $11.19 | ▲ +13.84% | ▲ +11.04% | $7.79 (−20.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers